- Home
- WFF vs NXTS Comparison
WFF vs NXTS Comparison
Compare WFF & NXTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WFF | NXTS |
|---|---|---|
| Founded | 1984 | 2009 |
| Country | Malaysia | Israel |
| Employees | 142 | 9 |
| Industry | Miscellaneous manufacturing industries | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 8.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WFF | NXTS |
|---|---|---|
| Price | $2.89 | $4.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 22.2K | ★ 2.2M |
| Earning Date | 05-24-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.18 | $0.55 |
| 52 Week High | $4.12 | $23.80 |
Technical Indicators
Market Signals| Indicator | WFF | NXTS |
|---|---|---|
| Relative Strength Index (RSI) | 66.63 | 47.76 |
| Support Level | $0.38 | $4.13 |
| Resistance Level | N/A | $5.97 |
| Average True Range (ATR) | 0.23 | 1.74 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 71.70 | 2.12 |
Price Performance
Historical ComparisonAbout WFF WF Holding Limited Ordinary Shares
WF Holding Ltd is a manufacturer of FRP products based in Malaysia. It has been providing high-quality and durable FRP products to various industries, including, among others, chemical processing, water and wastewater treatment, and power generation. Its products range from tanks, pipes, ducts, gratings, and other custom-made FRP products. Its manufacturing capabilities allow the company to design and fabricate products that meet the specific needs of its clients, ensuring high-quality and reliable performance. Geographically, the company generates the majority of its revenue from Australia.
About NXTS Nexentis Technologies Inc. Common Stock
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.